🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Javier Martín‐Broto

Hospital Universitario Fundación Jiménez Díaz

ORCID: 0000-0001-7350-6916

Also affiliated with Comunidad de Madrid, Universidad Autónoma de Madrid, Universidad Europea de Madrid

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.1Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis

Journal of Surgical Oncology(2022)10.1002/jso.27067
Top 31%
0.651DataRank
Top 31%12 citations

John H. Healey, Emanuela Palmerini, Sebastian Bauer, H.W.B. Schreuder, Andreas Leithner +13 more

Papers

Driven by 10 papers — median percentile 54. Top paper: “Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial”.

Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4592
N/A
2.3DataRank · unranked
46 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232
N/A
0.749DataRank · unranked
146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis

Journal of Surgical Oncology(2022)10.1002/jso.27067
Top 31%
0.651DataRank
Top 31%12 citations

John H. Healey, Emanuela Palmerini, Sebastian Bauer, H.W.B. Schreuder, Andreas Leithner +13 more

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies

The Oncologist(2023)10.1093/oncolo/oyad011
Top 46%
0.401DataRank
Top 46%10 citations

John H. Healey, Nicholas M. Bernthal, Sebastian Bauer, H.W.B. Schreuder, Andreas Leithner +10 more

Experience with Second-Line Trabectedin in Daily Clinical Practice: Case Studies

Future Oncology(2022)10.2217/fon-2022-0519
N/A
0.241DataRank · unranked
4 citations

Nadia Hindi, Giovanni Grignani, Alessandra Merlini, Tony Ibrahim, Axel Le Cesne +1 more

Translational Aspects of Epithelioid Sarcoma: Current Consensus

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2174
N/A
0DataRank · unranked
15 citations

Sophie Postel‐Vinay, Robert Nakayama, Noah Berlow, Andrea Bolzicco, Vincenzo Cerullo +21 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618
N/A
0DataRank · unranked
229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

Data from Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

(2023)10.1158/1078-0432.c.6530537
Top 100%
0DataRank
Top 100%0 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

84P Exploring BET inhibitors as promising agents for solitary fibrous tumor

ESMO Open(2025)10.1016/j.esmoop.2025.104397
N/A
0DataRank · unranked
0 citations

Yanjun Li, Pablo Romero, José I. López, John T. Nguyen, David S. Moura +4 more

Identification of BET inhibitors (BETi) against solitary fibrous tumor (SFT) through high-throughput screening (HTS)

Neoplasia(2025)10.1016/j.neo.2025.101244
N/A
0DataRank · unranked
0 citations

David S. Moura, Yi Li, Jesús M. López Martí, Paulino Gómez‐Puertas, John T. Nguyen +7 more